About this event
In the first session, IHI Executive Director Dr Pierre Meulien presented IHI and explained why we are launching a new European partnership for health. He also described what's new compared to the Innovative Medicines Initiative (IMI), and what will stay the same. IHI staff then presented opportunities for stakeholders to get involved in IHI, for example by applying to become a member of the IHI Science and Innovation Panel (SIP), or by becoming an expert evaluator. They also offered a preview of the draft topics under consideration for inclusion in the first IHI call for proposals.
The second session featured a high-level discussion during which representatives of the IHI partners, namely the European Commission, the European Parliament, COCIR, EFPIA , Vaccines Europe, EuropaBio and MedTech Europe, presented their vision for IHI.
Both sessions included time for questions from participants.
Agenda and presentation
Jean-Eric Paquet, Director-General, DG Research and Innovation, European Commission
Bernt Bieber, COCIR President & SVP Direct Sales Siemens Healthineers
Serge Bernasconi, Chief Executive Officer, MedTech Europe
Claire Skentelbery, Director General, EuropaBio
Sibilia Quilici, Executive Director, Vaccines Europe
Nathalie Moll, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
Maria da Graça Carvalho, MEP, European Parliament
Meet the speakers
Executive Director, IHI
Head of Scientific Operations, IHI
Director-General, DG Research and Innovation, European Commission
COCIR President & SVP Direct Sales Siemens Healthineers
Chief Executive Officer, MedTech Europe
Director General, EuropaBio
Executive Director, Vaccines Europe
Director General, European Federation of Pharmaceutical Industries and Associations
Member of European Parliament
Journalist and Moderator